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Edited by Hans EklundAbstract Elongation factor Tu (EF-Tu), the carrier of aa-
tRNA to the mRNA-programmed ribosome, is the target of four
families of antibiotics of unrelated structure, of which the action
is supported by two basic mechanisms. Kirromycin and enacy-
loxin block EF-Tu Æ GDP on the ribosome; pulvomycin and
GE2270 A inhibit the interaction of EF-Tu Æ GTP with aa-
tRNA. The crystallographic analysis has unveiled the structural
background of their actions, explaining how antibiotics of unre-
lated structures and binding modes and sites can employ similar
mechanism of action. The selective similarities and diﬀerences of
their binding sites and the induced EF-Tu conformations make
understand how nature can aﬀect the activities of a complex reg-
ulatory enzyme by means of low-molecular compounds, and have
proposed a suitable approach for drug design.
 2006 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Elongation factor Tu (EF-Tu), the most abundant protein of
the bacterial cell, plays a key role in the elongation process of
protein biosynthesis. In complex with GTP it transports the
aa-tRNA to the programmed ribosome (Fig. 1A). Moreover,
it can participate in other cellular processes, such as the strin-
gent response and as one of the four subunits of the viral RNA
replicase (for a review, see Ref. [1]). As a GTPase, EF-Tu cy-
cles between an active GTP-bound ‘‘on’’-form and an inactive
GDP-bound ‘‘oﬀ’’-form and undergoes a dramatic change of
conformation. In complex with the non-hydrolyzable GTP
analog GDPNP (guanylyliminodiphosphate) EF-Tu shows aAbbreviations: EF-Tu, elongation factor Tu; EF-Ts, elongation factor
Ts; D1, D2 and D3, domains 1, 2 and 3, respectively; SW1 and SW2,
switch 1 and switch 2 regions, respectively; Ec, Escherichia coli; Tt,
Thermus thermophilus; Ta, Thermus aquaticus; KIR, kirromycin; ENX,
enacyloxin IIa; PULVO, pulvomycin; GEA, GE2270 A; GDPNP,
GNP, guanylyliminodiphosphate; 3D, three-dimensional
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doi:10.1016/j.febslet.2006.07.039more compact organization of the three domains, while in
EF-Tu Æ GDP the organization is less compact and displays a
central hole and loose interfaces between the nucleotide-bind-
ing domain 1 (D1) and the domain-2,3 unit (Fig. 1B) [2–6].
After the ribosome EF-Tu is the major target of antibiotics
inhibiting protein synthesis, a property that emphasizes its cen-
tral role in cell growth. Four families of antibiotics of unre-
lated structures have EF-Tu as target (for reviews, see Refs.
[1,7]). They comprise a total of more than 30 members and
have selective antibacterial activities [8,9]. Their prototypes
are kirromycin (KIR), enacyloxin IIa (ENX), pulvomycin
(PULVO) and GE2270 A (GEA) (Fig. 1C, Ref. [10]). The elu-
cidation of the three-dimensional (3D) structure of their com-
plexes with EF-Tu started few years ago with EF-Tu Æ GDP in
complex with GEA [11] or methylkirromycin (also called auro-
dox) [12] and has recently received new impulses by the resolu-
tion of the active form of EF-Tu in complex with ENX [13],
ENX and Phe-tRNAPhe [13], KIR and Phe-tRNAPhe, 1 PUL-
VO [14] and GEA [14] (Table 1, Refs. [15–18]1,2). The to date
knowledge of the structure of at least one complex for each of
the 4 families of antibiotics has revealed common features and
selective diﬀerences that explain structure–function relation-
ships thus far hypothetical, allowing reliable predictions for
the still unsolved complexes.2. Mechanism of action of the EF-Tu-targeted antibiotics
Functional studies have shown that the inhibitory action of
these antibiotics in protein synthesis is based on two basic
mechanisms (Fig. 1A). KIR and ENX induce a constitutive
activation of EF-Tu Æ GDP [1,19] making this complex to stick
to the mRNA-programmed ribosome after aa-tRNA binding
and GTP hydrolysis, thus blocking the synthesis of a new pep-
tide bond. Diﬀerently, PULVO and GEA prevent the forma-
tion of a stable ternary complex between EF-Tu Æ GTP and
Phe-tRNA, hindering the activation of EF-Tu [20,21]. Here
we review the structural background of these two mechanisms
of actions.1 R.C. Nielsen, O. Kristensen, S. Thirup, J. Nyborg, M. Kjeldegaard,
P. Nissen (in preparation).
2 Unpublished.
blished by Elsevier B.V. All rights reserved.
Fig. 1. Properties of EF-Tu and its speciﬁc antibiotics. (A) EF-Tu cycle and antibiotic targets. An asterisk marks the GTP hydrolysis occurring on
the ribosome. (B) 3D overview of the GDP/GTP transition of EF-Tu superimposed on D2 and D3. Note the dramatic conformational change of D1
from EF-Tu Æ GDP to EF-Tu Æ GDPNP. D1, orange in EF-Tu Æ GDP and purple in EF-Tu Æ GDPNP; D2 green and D3 cyan; EF-Tu Æ GDP eﬀector
region with SW1 a-helix A00 unfolded in a b-hairpin and the SW2 a-helix B in grey; EF-Tu Æ GNP eﬀector region with SW1 a-helix A00 and the SW2 a-
helix B in yellow. The grey ball indicates the magnesium ion coordinated with the nucleotide. The arrows point to the changes in the position of D1
induced by the antibiotics; KIR and ENX extend the rolling of D1 Æ GDPNP(GNP) over the D2 and D3 (red arrow), while PULVO and GEA hinder
the completion of the antibiotic-free positioning of D1 Æ GNP over D2 and D3 (blue arrow). (C) Structures of the EF-Tu-targeted antibiotics. The
KIR active core is encircled in orange. Red parentheses in GEA mark the part of the side-chain that can be removed without loss of activity [10].
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Structure–function relationships and antibiotic design
As has been suggested by site-directed mutagenesis and
proved by crystallographic analysis, KIR and ENX binding
sites are both located at the domain-1,3 interface and share
marked similarities (Fig. 2A and B) [13,19]. Binding of KIR
to EF-Tu(Tt) Æ GDP by induced-ﬁt mechanism tightens up
the domain-1,3 interface [12] that in the antibiotic-free EF-
Tu(Ec) Æ GDP is loose and practically limited to the contacts
of Q124 (125 in EF-Tu(Tt)) with domain 3 [22]. As a conse-
quence of the KIR insertion, D1 is pushed upward and slightly
tilted forward rolling over domains 2 and 3 (D2 and D3) to a
greater extent than in the antibiotic-free ‘‘on’’-form despite the
bound GDP. EF-Tu Æ GDP Æ KIR shows a disordered ‘‘eﬀec-tor’’ region including switch 1 (SW1) [12], a structural element
that together with switch 2 (SW2) acts as pivot of the physio-
logical GDP/GTP-transition [2–6] (Fig. 1B). The GTP-like
conformation of EF-Tu Æ GDP Æ KIR explains why this com-
plex shares functional properties with the antibiotic-free
‘‘on’’-form, such as the formation of a stable complex with
aa-tRNA, that binds to the programmed ribosome [1,23]. Even
if the 3D structure of EF-Tu Æ GDP Æ ENX has yet to be solved
(we only know the corresponding structure containing
GDPNP), from structural and functional evidence [13,19]
one can infer the same basic mechanism as for KIR. EF-
Tu Æ GDPNP Æ ENX also shows a destabilized ‘‘eﬀector’’ re-
gion including a-helices A 0 and A00 due to a pronounced shift
of a-helix B [13]. As in the KIR complex, also with ENX the
D1 is pushed upward and slightly tilted forward causing a
Table 1
Available 3D models of EF-Tua
EF-Tu complexes Resolution (A˚) PDB accession code
EF-Tu(Tt) Æ GDPNP [2] 1.7 1EXM
EF-Tu(Ta) Æ GDPNP [3] 2.5 1EFT
EF-Tu(Ec) Æ GDP [4] 2.5 1DG1
EF-Tu(Ta) Æ GDP [5] 2.7 1TUI
EF-Tu(Ec) Æ GDP [6] 2.05 1EFT
EF-Tu Æ GDPNP Æ Phe-tRNAPhe [15] 2.7 1TTT
EF-Tu Æ GDPNP Æ Cys-tRNACys
0
[16] 2.6 1B23
EF-Tu(Ec) Æ EF-Ts(Ec) [17] 2.5 1EFU
EF-Tu(Tt) Æ EF-Ts(Tt) [18] 3.0 1AIP
EF-Tu(Tt) Æ GDP Æ methylkirromycin [12] 2.0 1HA3
EF-Tu Æ GDP Æ GEA [11] 2.35 1D8T
EF-Tu(Ec) Æ GDPNP Æ ENX [13] 2.3 2BVN
EF-Tu(Tt) Æ GDPNP Æ PULVO [14] 1.4 2C78
EF-Tu(Tt) Æ GDPNP Æ GEA [14] 1.6 2C77
EF-Tu(Ta) Æ GDPNP Æ ENX Æ Phe-tRNAPhe [13] 3.1 1OB5
EF-Tu(Ec) Æ GDPNP Æ KIR Æ Phe-tRNAPhe 1 3.35 1OB2
EF-Tu(Ta) Æ GDPNP Æ KIR Æ Phe-tRNAPhe 2 3.0
aFor a complete overview also the 3D models of the antibiotic-free EF-Tu complexes were reported.
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EF-Tu Æ GDPNP Æ ENX and EF-Tu Æ GDPNP Æ KIR the inter-
action of a-helix A00 with aa-tRNA restructures the ‘‘eﬀector’’
region [13]1 but the EF-Tu Æ GDP Æ antibiotic complex is not
released from the ribosome after GTP hydrolysis [1,19,23].
This proves that the disorder of this region is a consequence
of and not the reason for the antibiotic’s action. It seems plau-
sible that KIR and ENX freeze an EF-Tu conformation,
occurring on the ribosome [13],1 [24].Fig. 2. Crystallographic model of EF-Tu Æ GDP Æ (methyl)KIR (A) and EFT
blue. The nucleotide (GDP in EF-Tu(Tt) Æ KIR and GDPNP in EF-Tu(Ec) Æ E
red, nitrogen blue and chlorines green. Grey ball: magnesium ion coordinated
juxtaposed hydrophobic pocket (also depicted in the ENX complex) in b
is undeﬁned since it does not show any electronic density [12,13]. In E
Tu Æ GDPNP Æ ENX a-helix A 0 could not be traced while SW1 a-helix A00 apLocal but relevant diﬀerences characterize the binding of the
two antibiotics [13]: KIR displays multiple contacts with Q124
diﬀerently from ENX that only steers this central residue of the
domain-1,3 interface and, most important, the ‘‘tail’’ of KIR
comprising the terminal diene moiety (Figs. 1C and 2A) enters
a juxtaposed, empty hydrophobic pocket (Fig. 2A, black cir-
cle) whereas the shorter ‘‘tail’’ of ENX does not (Fig. 2B, black
circle). These divergences, that also explain the diﬀerential ef-
fect of the substitution Ala375ﬁ Val on the EF-Tu sensitivityu Æ GDPNP Æ ENX (B). D1 is depicted in red, D2 in green and D3 in
NX) is represented in balls and sticks with the carbons yellow, oxygens
with the nucleotide. The KIR active core is encircled in orange and the
lack. Note. Part of the eﬀector region of the two EF-Tu complexes
F-Tu Æ GDP Æ (methyl)KIR only a-helix A 0 could be traced. In EF-
pears unwound and collapsed in D2 (see arrow in panel B).
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sons for the stronger binding aﬃnity of KIR for EF-Tu vs
ENX [13,25]. Since the ‘‘tail’’ moiety, whose structure diﬀers
from that of ENX, constitutes the active core of KIR [26,27]
(see the KIR moiety encircled in orange in Figs. 1C and 2A)
the synthesis of structural KIR/ENX hybrids has been pro-
posed to obtain compounds with novel properties, e.g. higher
or lower aﬃnity to EF-Tu [13]. This approach could extend to
derivatives of both antibiotics or to other compounds comple-
menting structural features of the antibiotic binding sites.4. EF-Tu binding sites for PULVO and GEA and conformation
of the relative complexes
The PULVO and GEA binding sites on EF-Tu Æ GDPNP
diﬀer more markedly than those of KIR and ENX [13,14].
PULVO intimately contacts all three domains (Fig. 3A). Its
lactone ring binds at the domain-1,3 interface proximal to
the 3-domain junction, the linear side chain overlaps this junc-
tion and the terminal moiety covers part of the binding site of
the thiazolyl peptide ring of GEA in domain 2 (D2) [14]. GEA
binds to D2, the upper part of its thiazolyl ring contacting
D1 in EF-Tu Æ GDPNP (Fig. 3A) [14]. In contrast, in EF-
Tu Æ GDP (Fig. 3B) the upper part of the thiazolyl ring is ex-
posed to the solvent, as a consequence of the conformational
change induced by GDP on EF-Tu [11]. The partially overlap-
ping binding sites of the two antibiotics (Fig. 3A) only share 7
amino acids out of the more than 20 contacted at <3.8 A˚, but
both interfere with the binding of the 3 0 end of aa-tRNA [14].
PULVO also contacts amino acid residues binding to the 5 0
end of tRNA. As shown in Fig. 3A, this antibiotic physically
blocks the interaction between D1 and aa-tRNA. The bindingFig. 3. PULVO and GEA interfere with the Phe-tRNAPhe binding site on E
Tu Æ GDP (B). (A) The D3 of the crystallographic models of EF-Tu Æ GDPNP
and antibiotic in blue) and the ternary complex EF-Tu Æ GDPNP Æ Phe-tRNA
only a few structural elements of D2 in green and D3 in cyan are depicted an
R300 and D348 are three key amino acid residues of the binding site of the Ph
Tu Æ GDP Æ GEA emphasizing the gap between D1 and D2 as in the antibiotof PULVO and GEA widens the domain-1,2 interface, hinder-
ing by steric hindrance the completion of the rolling of D1 over
D2 and D3 [14]. This eﬀect contrasts with that of ENX and
KIR, which widens the domain-1,3 interface and extends the
rolling of D1 over D2 and D3 [13]. Diﬀerently from ENX
and KIR, PULVO and GEA do not essentially change the
relationships of the structural elements of D1 that virtually
moves as a rigid body (Fig. 3A) [14]. Taken together these ef-
fects prove that the inhibition of aa-tRNA binding by PULVO
and GEA depends on a simple competition between overlap-
ping binding sites, diﬀerently from KIR or ENX whose inhibi-
tion of the EF-Tu functions depends on long-range eﬀects.
Interestingly, the analysis on PAGE strongly suggests that
the conformation of the as yet unsolved EF-Tu Æ GDP Æ PUL-
VO complex diﬀers from EF-Tu Æ GDP Æ GEA and predicts a
more compact organization similar to that of EF-Tu Æ GDPN-
P Æ PULVO [14]. The intimate interaction of PULVO with all
three domains of EF-Tu is likely to ﬁx their relative positions,
hindering extensive displacements as those induced by GDP on
the antibiotic-free EF-Tu or on EF-Tu Æ GEA (Figs. 1B and
3B). Similarly to KIR and ENX, the amino acid substitutions
inducing resistance to PULVO and GEA lie in the area of their
binding sites [13,14]; this emphasizes a direct structure–func-
tional correlation in the EF-Tu Æ antibiotic complexes.5. SW1 and SW2 regions, GTPase activity and GTP binding
aﬃnity
The reason for these antibiotics to contact the D1 interfaces
resides in the strategic function of these areas that via the
switch regions communicate with the nucleotide binding
pocket and thus mediate the GDP/GTP-dependent signalsF-Tu (A). GEA contacts the D1 in EF-Tu Æ GDPNP but not in EF-
Æ PULVO (D1 and antibiotic in magenta), EF-Tu Æ GDPNP Æ GEA (D1
Phe (D1 not illustrated) were superimposed. Of the antibiotic complexes
d of the ternary complex only Phe-tRNAPhe in grey is illustrated. K90,
e-tRNA 5 0 end. R300 also contacts PULVO. (B) Representation of EF-
ic-free EF-Tu Æ GDP. Colour scheme as in A.
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the interactions with ligands. Diﬀerently from the dramatic
changes of the SW1 region induced by KIR and ENX, minor
changes were found in the SW2 region and its neighbourhood
[13,14]. Worth mentioning is H84 (85 in EF-Tu(Tt)) a residue
involved in the EF-Tu-dependent GTPase activity, which has
been object of extensive speculations, e.g. the proposed partic-
ipation of its side-chain in a nucleophilic attack on the nucle-
otide c-phosphate [2,7]. In EF-Tu Æ GDP Æ KIR and EF-
Tu Æ GDPNP Æ GEA, diﬀerently from the ENX and PULVO
complexes, its side chain is turned toward the phosphoryl
groups of the nucleotide [13,14]. However, analysis of the
GTPase activity of the EF-Tu Æ antibiotic complexes and of
H84 mutants in the absence and presence of programmed ribo-
some does not support a direct involvement of the H84 side-
chain in the GTP c-phosphate hydrolysis, suggesting a key
but indirect role in favoring the active conformation of the
nucleotide binding site [1,28,29]. All of the three antibiotics
enhancing the intrinsic GTPase of EF-Tu (KIR, ENX and
PULVO, of which KIR is the most eﬃcient [13,30]) interact
with the domain-1,3 interface. That perturbation of this area
in close contact with the nucleotide binding pocket via the
switch regions can inﬂuence the cleavage of the GTP c-phos-
phate likely depends on local pH and salt eﬀects, in agreement
with a substrate-assisted GTP hydrolysis, the to date most
probable mechanism for the low intrinsic GTPase activity of
EF-Tu [31]. Any model for the ten-thousands of times faster
EF-Tu GTP hydrolysis dependent on programmed ribosomes
still remains an object of speculation [1,32]. Microenvironmen-
tal changes, unperceivable by crystallographic analysis, are
probably involved also in the strongly increased GTP-binding
aﬃnity for EF-Tu induced by all the four antibiotics [1,23].
The resulting high-aﬃnity EF-Tu Æ GTP complex likely
represents a frozen transient precursor of the low-aﬃnity
EF-Tu Æ GTP complex observed in physiological conditions.6. Conclusions
For the future, the elucidation of the 3D structure of EF-
Tu Æ GDP Æ PULVO represents a priority as well as the exploi-
tation of the EF-Tu binding properties of these antibiotics for
the productions of novel compounds. In this context one
should characterize the active cores of ENX, PULVO and
GEA and engineer structural analogs of these antibiotics.
The integration of functional and structural methods remains
determinant for understanding how nature can aﬀect the activ-
ities of a complex regulatory enzyme by means of low-molec-
ular, structurally unrelated compounds.References
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